Proton vs carbon ion beams in the definitive radiation treatment of cancer patients

Radiotherapy and Oncology

Volumn 95, Issue 1, 2010, Pages 3-22

  Suit, Herman ^a   DeLaney, Thomas ^a   Goldberg, Saveli ^a   Paganetti, Harald ^a   Clasie, Ben ^a   Gerweck, Leo ^a   Niemierko, Andrzej ^a   Hall, Eric ^b   Flanz, Jacob ^a   Hallman, Josh ^a   Trofimov, Alexei ^a  

^a Department of Radiation Oncology ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Carbon ions; NTCP; Protons; TCP

Indexed keywords

ADENOID CYSTIC CARCINOMA; AIRWAY OBSTRUCTION; ANDROGEN DEPRIVATION THERAPY; BLADDER DISEASE; BONE NECROSIS; BRACHIAL PLEXOPATHY; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL DIVISION; CELL TRANSFORMATION; CHONDROSARCOMA; CHORDOMA; DYSPHAGIA; FAST NEUTRON THERAPY; FEASIBILITY STUDY; HEAD AND NECK CANCER; HEMATURIA; HUMAN; INTERMETHOD COMPARISON; ION THERAPY; KIDNEY CARCINOMA; LINEAR ENERGY TRANSFER; LIVER CELL CARCINOMA; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; MELANOMA; NEUROPATHY; NEUTRON THERAPY; NONHUMAN; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PAROTID GLAND CARCINOMA; PHYSICS; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSTATE CANCER; PROSTATE CARCINOMA; PROTON THERAPY; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RECTUM HEMORRHAGE; RECTUM INJURY; REVIEW; RIB FRACTURE; SACRUM CHORDOMA; SALIVARY GLAND TUMOR; SKIN DEFECT; SKULL BASE CHONDROSARCOMA; SKULL BASE CHORDOMA; SOFT TISSUE SARCOMA; SQUAMOUS CELL CARCINOMA; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT OUTCOME; TUMOR BIOPSY; URETHRA DISEASE; URETHRA STRICTURE; UVEA MELANOMA;

CARBON; FAST NEUTRONS; HEAVY IONS; HUMANS; LINEAR ENERGY TRANSFER; NEOPLASMS; PROTONS; RELATIVE BIOLOGICAL EFFECTIVENESS;

EID: 77950334390     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.01.015     Document Type: Review

References (136)

1. Delaney T., and Kooy H. Proton and charged particle radiotherapy (2008), Philadelphia, Lippincott Williams & Wilkins
2. Goitein M. Trials and tribulations in charged particle radiotherapy. Radiother Oncol (2009) [Epub ahead of print]
3. Jones B. Presidents conference paper. The case for particle therapy. Br J Radiol 79 (2006) 24-31
4. Schulz-Ertner D., and Tsujii H. Particle radiation therapy using proton and heavier ion beams. J Clinical Oncol 25 (2007) 953-964
5. Turesson I., Johansson K., and Mattisson S. The potential of proton and light ion beams in radiotherapy. Acta Oncol 42 (2003) 107-114
6. Weber U., and Kraft G. Comparison of carbon ions versus protons. Cancer J 15 (2009) 325-332
7. Brada M., Pijls-Johannesma M., and Dose Ruysscher D. Current clinical evidence for proton therapy. Cancer J 15 (2009) 319-324
8. Wilkens J., and Oelfke U. Direct comparison of biologically optimized spread-out Bragg peaks for protons and carbon ions. Int J Rad Oncol Biol Phys 70 (2008) 262-266
9. Brown A., and Suit H. The centenary of the discovery of the Bragg peak. Radiother Oncol 73 (2004) 265-268
10. Pshenichnov I., Mishustin I., and Greiner W. Neutrons from fragmentation of light nuclei in tissue like media: a study with the GEANT4 toolkit. Phys Med Biol 50 (2005) 5493-5507
11. Lomax A., Bortfeld T., Goitein G., et al. A treatment planning inter-comparison of proton and intensity modulated photon radiotherapy. Radiother Oncol 51 (1999) 257-271
12. Endo S., Takada M., Onizuka Y., et al. Microdosimetric evaluation of secondary particles in a phantom produced by carbon 290 MeV/nucleon ions at HIMAC. J Radiat Res 48 (2007) 397-406
13. 12C therapy beams. Radiat Prot Dosimetry 122 (2006) 485-487
14. Blakely E.A., Tobias C.A., Tracy C.H., et al. Inactivation of human kidney cells by high-energy mono-energetic heavy ion beams. Radiat Res 80 (1979) 122-160
15. Kanai T., Endo M., Minohara S., et al. Biophysical characteristics of HIMAC clinical irradiation system for heavy ion radiation therapy. Int J Rad Oncol Biol Phys 44 (1999) 201-210
16. Wroe A., Clasie B., Kooy H., et al. Out-of field dose equivalents delivered by passively scattered therapeutic proton beams for clinically relevant field configurations. Int J Rad Oncol Biol Phys 71 (2009) 306-313
17. Safai S., Bortfeld T., and Engelsman M. Comparison between the lateral penumbra of a collimated double-scattered beam and uncollimated scanning beam in proton radiotherapy. Phys Med Biol 53 (2008) 1729-1750
18. Lomax A., Pedroni E., Rutz H., and Goitein G. The clinical potential of intensity modulated proton therapy. Z Med Phys 14 (2004) 147-152
19. Kramer M., Jakel O., Haberer T., et al. Treatment planning for scanned ion beams. Radiother Oncol 73 (2004) 80-85
20. 12C beams. Med Phys 34 (2007) 183-192
21. Wroe A., Rosenfeld A., and Schulte R. Out-of-field dose equivalents delivered by proton therapy of prostate cancer. Med Phys 34 (2007) 3449-3456 Dosage error in article text. 2008; 35:3398
22. Mesoloras G., Sandison G., Stewart R., et al. Neutron scattered dose equivalent to a fetus from proton radiotherapy of the mother. Med Phys 33 (2006) 2479-2490
23. Yonai S., Matsufuji N., Kanai T., et al. Measurement of neutron ambient dose equivalent in passive carbon-ion and proton radiotherapies. Med Phys 35 (2008) 4782-4792
24. Stovall M., Blackwell C., Cundiff J., et al. Fet al. dose from radiotherapy with proton beams: report of AAPM Radiation Therapy Committee Task Group No 36. Med Phys 22 (1995) 63-82
25. Schneider U., Agosteo S., Pedroni E., et al. Secondary neutron dose during proton therapy using spot scanning. Int J Radiat Oncol Biol Phys 53 (2002) 244-251
26. Tsujii H., Minohara S., and Noda K. Heavy particle radiation therapy: system design and application. Reviews of Accelerator Science and Technology 2 (2009) 93-110
27. Goitein M. Compensation for inhomogeneities in charged particle radiotherapy using computed tomography. Int J Rad Oncol Biol Phys 4 (1978) 499-508
28. Urie M., Goitein M., and Wagner M. Compensating for heterogeneities in proton radiation therapy. Phys Med Biol 29 (1984) 553-566
29. Weber U., and Kraft G. Comparison of carbon ions vs protons. He Cancer J 15 (2009) 325-332
30. Prescribing, Recording, and Reporting Proton-Beam Therapy. Report 78, J Int Comm Radiat Units Meas 2007;7:2.
31. Paganetti H., Niemierko A., Ancukiewicz M., et al. Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys 53 (2002) 407-421
32. Gerweck L., and Kozin S. Relative biological effectiveness of proton beams in clinical therapy. Radiother Oncol 50 (1999) 135-142
33. Warenius H., Britten R.A., and Peacock J.H. The relative cellular radiosensitivity of 30 human in vitro cell lines of different histological type to high LET 62.5 MeV (p → Be+) fast neutrons and 4 MeV photons. Radiother Oncol 30 (1994) 83-89
34. Suzuki M., Kase Y., Yamaguchi H., et al. Relative biological effectiveness for cell-killing effect on various human cell lines irradiated with heavy-ion medical accelerator in Chiba (HIMAC) carbon ion beams. Int J Rad Oncol Biol Phys 48 (2000) 241-250
35. Ando K., and Kase Y. Biological characteristics of carbon-ion therapy. Int J Radiati Biol 85 (2009) 715-728
36. Weyrather W., Ritter S., Scholz M., et al. RBE for carbon track-segmented irradiation in cell lines of differing repair capacity. Int J Radiat Biol 75 (1999) 1357-1364
37. 12C-, and 20Ne-ion beams. Radiat Res 154 (2000) 485-496
38. Karger C., Peschke P., Sanchez-Brandelik R., et al. Radiation tolerance of the rat spinal cord after 6 and 18 fractions of photons and carbon ions: experimental results and clinical implications. Int J Rad Oncol Biol Phys 66 (2006) 1488-1497
39. Robbins M., Barnes D., Campling D., et al. The relative biological effectiveness of fractionated doses of fast neutrons (42 MeVd--Be), for normal tissues in the pig. IV. Effects on renal function. Br J Radiol 64 (1991) 823-830
40. Hall E., and Giacci A. Radiobiology for the radiologist. Sixth edition (2006), Philadelphia PA, Lippincott Williams and Wilkins
41. Becker A., Hänsgen G., Bloching M., et al. Oxygenation of squamous cell carcinoma of the head and neck: comparison of primary tumors, neck node metastases, and normal tissue. Int J Radiat Oncol Biol Phys 42 (1998) 35-41
42. Brizel D., Dodge R., Clough R., et al. Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome. Radiother Oncol 53 (1999) 113-117
43. Nordsmark M., Bentzen S., Rudat V., et al. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol 77 (2005) 18-24
44. Parker C., Milosevic M., Toi A., et al. Polarographic electrode study of tumor oxygenation in clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 58 (2004) 750-757
45. Blakely E. Biology of bevalac beam: cellular studies. In: Skarsgard L. (Ed). Pion and heavy ion radiation therapy: pre-clinical and clinical studies (1982), Elsevier, Amsterdam 229-250
46. Raju M. Heavy particle radiotherapy. Academic Press, Inc.: New York, NY; 1980.
47. Miller R., Marino S., Martin S., et al. Neutron-energy dependent cell survival and oncogenic transformation. J Radiat Res 40 (1999) 53-59
48. Han Z., Suzuki H., Suzuki F., et al. Relative biological effectiveness of accelerated heavy ions for induction of morphological transformation in Syrian hamster embryo cells. J Radiat Res 39 (1998) 193-201
49. Bettega D., Calzolari P., Hessel P., et al. Neoplastic transformation induced by carbon ions. Int J Radiat Oncol Biol Phys 3 (2009) 861-868
50. Stone R. Neutron therapy and specific ionization. Janeway Memorial Lecture. Am J Roentgenol Radium Ther 59 (1948) 771-785
51. Catterall M., Bewley D., and Sutherland I. Second report of a randomized clinical trial of fast neutrons compared with chi or gamma rays in treatment of advanced tumours of head and neck. Br Med J 1 (1977) 1642
52. Stafford N., Waldron J., Davies D., et al. Complications following fast neutron therapy for head and neck cancer. J Laryngol Otol 106 (1992) 144-146
53. Blake P., Catterall M., and Eddington R. Treatment of malignant melanoma by fast neutrons. Br J Surg 72 (1985) 517-519
54. MacDougall R., Orr J., Kerr G., et al. Fast neutron treatment for squamous cell carcinoma of the head and neck: final report of Edinburgh randomized trial. Br Med J 301 (1990) 1241-1242
55. Maor M., Errington D., Caplan R., et al. Fast-neutron therapy in advanced head and neck cancer. Int J Rad Oncol Biol Phys 32 (1995) 599-604
56. Overgaard J. Hypoxic radiosensitization: adored and ignored. J Clin Oncol 25 (2007) 4066-4074
57. Lindsely K., CHO P., and Stelzer K. Clinical trials of neutron therapy in the United States. Bull Cancer/Radiother 83 (1996) 78s-86s
58. Laramore G., Krall J., Griffin T., et al. Neutron versus photon for unresectable salivary gland tumors: final report of an RTOG-MRC randomized trial. Int J Rad Oncol Biol Phys 27 (1993) 235-240
59. Griffin B., Laramore G., Russell K., et al. Fast neutron radiation therapy for advanced malignant salivary gland tumors. Radiother Oncol 12 (1988) 105-111
60. Wang C., and Goodman M. Photon irradiation on unresectable carcinomas of salivary glands. Int J Rad Oncol Biol Phys 21 (1991) 567-569
61. Wijffels K., Hoogsteen I., Lok J., et al. No detectable hypoxia in malignant salivary gland tumors: preliminary results. Int J Rad Oncol Biol Phys 73 (2009) 1319-1325
62. Laramore G., and Griffin T. Fast neutron radiotherapy: where have we been and where are we going? Jury is still out-regarding Maor et al. Int J Rad Oncol Biol Phys 32 (1995) 879-882
63. Duncan W. An evaluation of the results of neutron therapy trials. Acta Oncol 33 (1994) 299-306
64. Wagner F., Kneschaurek P., Kastenmüller A., et al. The Munich fission neutron therapy facility MEDAPP at the research reactor FRM II. Strahlenther Onkol 184 (2008) 643-646
65. Fowler J. The linear quadratic formula and progress in fractionated radiation therapy. Br J Radiol 62 (1989) 679-692
66. Fowler J. Sensitivity analysis of paramentes in linear quadratic radiobiologic modeling. Int J Radiat Oncol Biol Phys 73 (2009) 1532-1537
67. Stuschke M., and Pottgen C. Altered fractionation schemes in radiotherapy. Front Radiat Ther Oncol 42 (2010) 150-156
68. Iwata H., Shibamoto Y., Murata R., et al. Estimation of errors associated with use of linear-quadratic formalism for evaluation of biologic equivalence between single and hypofractionated radiation doses: an in vitro study. Int J Radiat Oncol Biol Phys 75 (2009) 482-488
69. Joiner M., and van der Kogel B. Basic clinical radiobiology. Fourth edition (2009), Hodder-Arnold Publishing, London
70. Kirkpatrick J., Meyer J., and Marks L. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Semin Radiat Oncol 18 (2008) 240-243
71. Brenner D. The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. Semin Radiat Oncol 18 (2008) 234-239
72. Gunderson L, Tepper, editors. Clinical radiation oncology. New York: Churchill Livingstone; 2000.
73. Halperin E, Perez C, Brady L, editors. Principles and practice of radiation oncology. Philadelphia: Lippincott Williams and Wilkins; 2008, p. 2-75.
74. Peckham M et al., editors. Oxford textbook of oncology. Oxford Medical Publications; 1995.
75. Henderson F., McCool K., Seigle J., et al. Treatment of chordomas with CyberKnife: Georgetown University experience and treatment recommendations. Neurosurgery 64 (2009) A44-A53
76. Bentzen S., and Ritter M. The α/β ratio for prostate cancer: What is it, really?. Radiother Oncol 76 (2005) 1-3
77. Williams S., Taylor J., Liu N., Tra Y., et al. Use of individual fraction size data from 3756 patients to directly determine the alpha/beta ratio of prostate cancer. Int J Radiat Oncol Biol Phys 68 (2007) 24-33
78. Koukourakis M., Skarlatos J., Kosma L., et al. Radiotherapy alone for non-small cell lung carcinoma. Five-year disease-free survival and patterns of failure. Acta Oncol 34 (1995) 525-530
79. Zeman E. Biological basis of radiation oncology. In: Gunderson L., and Tepper J. (Eds). Clinical radiation oncology (2000), Churchill Livingstone, New York 1-41
80. Tai A., Erickson B., Khater K., et al. Estimate of radiobiologic parameters from clinical data for biologically based treatment planning for liver irradiation. Int J Radiat Oncol Biol Phys 70 (2008) 900-907
81. Toya R., Murakami R., Yasunaga T., et al. Radiation therapy for lymph node metastases from hepatocellular carcinoma. Hepatogastroenterology 56 (2009) 476-480
82. Terahara A., Niemierko A., Goitein M., et al. Analysis of the relationship between tumor dose inhomogeneity and local control in patients with analysis of the relationship between tumor dose inhomogeneity and local control in patients with skull base chordoma. Int J Radiat Oncol Biol Phys 45 (1999) 351-358
83. Noël G., Feuvret L., and Calugaru V. Et al. Chordomas of the base of the skull and upper cervical spine. One hundred patients irradiated by a 3D conformal technique combining photon and proton beams. Acta Oncol 44 (2005) 700-708
84. Noël G., Feuvret L., Ferrand R., et al. Radiotherapeutic factors in the management of cervical-basal chordomas and chondrosarcomas. Neurosurg 55 (2004) 1252-1261
85. Hug E., Loredo L., Slater J., et al. Proton radiation therapy for chordomas and chondrosarcomas of the skull base. J Neurosurg (1999) 432-439
86. Ares C., Hug E., Lomax A., et al. Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: first long-term report. Int J Rad Oncol Biol Phys 75 (2009) 1111-1118
87. Debus J., Schulz-Eernter D., Schad L., et al. Stereotactic fractionated radiotherapy for chordomas and chondrosarcomas of the skull base. Int J Rad Oncol Biol Phys 47 (2000) 591-596
88. Hasegawa A, Mizoe J, Takagi R, et al. Carbon ion radiotherapy for skull base and paracervical tumors. In: Proceedings of NIRS MD Anderson symposium on clinical issues for particle therapy; 2008. p. 84-9.
89. Schulz-Ertner D., Karger C., Feuerhake A., et al. Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas. Int J Rad Oncol Biol Phys 68 (2007) 449-457
90. Miyawaki D., Murakami M., Demizu Y., et al. Brain injury after proton therapy or carbon ion therapy for head-neck cancer and skull base tumors. Int Nat J Radiat Oncol Biol Phys 75 (2009) 478-484
91. Martin J., Niranjan A., Kondziolka D., et al. Radiosurgery for chordomas and chondrosarcomas of the skull base. J Neurosurg 107 (2007) 758-764
92. Rosenberg A., Nielsen G., Keel S., et al. Chondrosarcoma of the base of the skull: a clinicopathological study of 200 cases with emphasis on it's distinction from chordoma. Am J Surg Path 23 (1999) 1370-1378
93. Schulz-Ertner D., Nikoghosyan A., Holger H., et al. Carbon ion radiotherapy of skull base chondrosarcomas. Int J Rad Oncol Biol Phys 67 (2007) 171-177
94. Imai R., Kamada T., Tsuji H., et al. Carbon ion radiotherapy for unresectable sacral chordomas. Cl Cancer Res 10 (2004) 5741-5746
95. Delaney T., Liebsch N., Pedlow F., Adams J., et al. Phase II study of high-dose photon/proton radiation therapy in the management of spine sarcomas. Int J Radiol Biol Phys 74 (2009) 732-739
96. Rutz H., Weber D., Sugahara S., et al. Extracranial chordoma: outcome in patients treated with function-preserving surgery followed by spot-scanning proton beam irradiation. Int J Radiat Oncol Biol Phys 67 (2007) 512-520
97. Gragoudas E., Wenjun L.I., Goitein M., et al. Evidence-based estimates of outcome in patients irradiated for intraocular melanoma. Arch Opthalmol 120 (2002) 1665-1671
98. Gragoudas E. Proton beam irradiation of uveal melanomas: the first 30 years. The Weisenfeld lecture. IVOS 47 (2006) 4666-4673
99. Egger E., Schalenbourg A., Zografos L., et al. Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma. Int J Rad Oncol Biol Phys 51 (2001) 138-147
100. Egger E., Zografos L., Schalenbourg A., et al. Eye retention after proton beam radiotherapy for uveal melanoma. Int J Rad Oncol Biol Phys 55 (2003) 867-880
101. Dendale R., Rouic L., Noel G., et al. Proton beam radiotherapy for uveal melanoma: results of Curie Institute-Orsay Proton Therapy Center. Int J Rad Oncol Biol Phys 65 (2006) 780-787
102. Tsuji H., Ishikawa H., Yanagi T., et al. Carbon-ion radiotherapy for locally advanced or unfavorably located choroidal melanoma: a phase I/II dose-escalation study. Int J Rad Oncol Biol Phys 67 (2007) 857-862
103. Dieckmann K., Georg D., Bogner J., Zehetmayer M., et al. Optimizing Linac-based stereotactic radiotherapy of uveal melanomas: 7 years' clinical experience. Int J Rad Oncol Biol Phys (2006) S47-S52
104. Slater J., Yonemoto L., Mantik D., et al. Proton radiation for treatment of cancer of the oropharynx: early experience at Loma Linda University Medical Center using a concomitant boost technique. Int J Rad Oncol Biol Phys 62 (2005) 494-500
105. Mizoe J, Hasegawa A, Takagi R, et al. Carbon ion radiotherapy for head and neck tumors. In: Proceedings of NIRS MD Anderson symposium on clinical issues for particle therapy; 2008. p. 9-15.
106. Pommier P., Liebsch N., Deschler D., et al. Proton beam radiation therapy for skull base adenoid cystic carcinoma. Arch Otolaryngol Head Neck Surg 132 (2006) 1242-1249
107. Schulz-Ertner D., Nikoghosyan A., Didinger B., et al. Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniques. Cancer 104 (2005) 338-344
108. Schulz-Ertner D., Nikoghosyan A., and Jäekel O. Feasibility and toxicity of combined photon and carbon ion radiotherapy for locally advanced adenoid cystic carcinomas. Int J Rad Oncol Biol Phys 56 (2003) 309-604
109. Mizoe J., Tsujii H., Kamada T., et al. Dose escalation study of carbon ion radiotherapy for locally advanced head and neck cancer. Int J Rad Oncol Biol Phys 60 (2004) 358-364
110. Douglas J., Lee S., Laramore G., et al. Neutron Radiotherapy for the treatment of locally advanced major salivary gland tumors. Head Neck 21 (1999) 255-263
111. Yanagi T., Mizoe J., Hasegawa A., et al. Mucosal malignant melanoma of the head and neck treated by carbon ion radiotherapy. Int J Rad Oncol Biol Phys 74 (2009) 15-20
112. Bush D., Slater J., Shin B., et al. Hypofractionated proton beam radiotherapy for stage I lung cancer. Chest 126 (2004) 1198-1203
113. Nihei K., Ogino T., Ishikura S., et al. High dose proton beam therapy for Stage I non-small cell lung cancer. Int J Rad Oncol Biol Phys 65 (2006) 107-111
114. Hata M., Tokuuye K., Kagel K., et al. Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study. Int J Rad Oncol Biol Phys 68 (2007) 786-793
115. Miyamoto T., Baba M., Yamamoto N., et al. Curative treatment of stage I non-small cell lung cancer with carbon ion beams using a hypofractionated regimen. Int J Rad Oncol Biol Phys 67 (2007) 750-758
116. Fakiris A., Henderson M.A., Witt T.C., et al. Gamma-knife based Stereotactic radiosurgery for uveal melanoma. Stereotact Funct Neurosurg 85 (2007) 106-112
117. Timmerman R., McGarry R., Yiannoutsos C., et al. Excessive toxicity when treating central tumors in a Phase II study of Stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 24 (2006) 4833-4837
118. Ng A., and Tung S. Wong V Hypofractionated stereotactic radiotherapy for medically inoperable stage I non-small cell lung cancer-report on clinical outcome and dose to critical organs. Radiother Oncol 87 (2008) 24-28
119. Hoyer M., Roed H., Hansen A., et al. Prospective study on stereotactic radiotherapy of limited-stage non-small-cell lung cancer. Int J Rad Oncol Biol Phys 66 (2006) S128-S135
120. Koto M., Takai Y., Ogawa Y., et al. A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancer. Radiother Oncol 85 (2008) 429-434
121. Forquer J, Fakiris A, Timmerman R, et al. Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites. Radiother Oncol 2009;May 17 [E Pub ahead of print].
122. Pettersson N., Nyman J., and Johansson K. Radiation induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: A dose and volume response analysis. Radiother Oncol 91 (2009) 360-368
123. Fukumitsu N., Sugahara S., Nakayama H., et al. A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 74 (2009) 831-836
124. Chiba T., Tokuuye K., Matsuzaki Y., et al. Proton beam therapy for hepatocellular carcinoma: a retrospective review of 162 patients. Clin Cancer Res 11 (2005) 3799-3805
125. Kato H, Yassda S, Yamada S, et al. Carbon ion radiotherapy for hepatocellular carcinoma [HCC, hepatoma]. In: Proceedings of NRS MD Anderson symposium on clinical issues for particle therapy; 2008. p. 16-23.
126. Mornex F., Girard N., Beziat C., et al. Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies-mature results of the French Phase II RTF-1 trial. Int J Radiat Oncol Biol Phys 66 (2006) 1152-1158
127. Shipley W., Verhey L., Munzenrider J., et al. Advanced prostate cancer: The results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int J Rad Oncol Biol Phys 31 (1995) 3-12
128. Slater J., Rossi C., Yonemoto L., et al. Proton therapy for prostate cancer: the initial Loma Linda University experience. Int J Rad Oncol Biol Phys 59 (2004) 348-352
129. Zietmann A., De Silvio M., Slater J., et al. Comparison of conventional dose vs high dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate. JAMA 294 (2005) 1233-1239
130. Tsuji H, Kato H, Yanhai T, et al. Carbon ion therapy for prostate cancer. In: Proceedings of NIRS MD anderson symposium on clinical issues for particle therapy; 2008. p. 62-71.
131. Zelefsky M., Chan H., Hunt M., et al. Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer. J Urol 176 (2006) 1415-1419
132. Zelefsky M., Yamada Y., Cohen G., et al. Five year outcome of intra-operative conformal permanent I-125 interstitial implantation for patients with clinically localized prostate cancer. Int J Rad Oncol Biol Phys 67 (2007) 65-70
133. Nomiya T., Tsuji H., Hirasawa N., et al. Carbon ion radiation therapy for primary renal cell carcinoma: initial clinical experience. Int J Rad Oncol Biol Phys 72 (2008) 828-833
134. Preston D., Shimizu Y., Pierce D., et al. Studies of mortality of atomic bomb survivors. Report 13: solid cancer and non-cancer disease mortality: 1950-1997. Radiat Res 160 (2003) 381-407
135. Suit H., Goldberg S., Niemierko A., et al. Secondary carcinogenesis in patients treated with radiation: a review of data on radiation-induced cancers in human, non-human primate, canine and rodent subjects. Radiat Res 167 (2007) 12-42 Erratum in: Radiat Res 2007;167:748
136. Chao K., Blanco A., and Dempsey J. A conceptual model integrating spatial information to assess target volume coverage for IMRT treatment planning. Int J Rad Oncol Biol Phys 56 (2003) 1438-1449